###begin article-title 0
Systemic Inhibition of NF-kappaB Activation Protects from Silicosis
###end article-title 0
###begin p 1
###xml 293 301 <span type="species:ncbi:9606">patients</span>
Conceived and designed the experiments: FG GWH GDL LAO. Performed the experiments: MDG FG GWH SAY NK GDL LAO. Analyzed the data: MDG FG GWH GL SMS TJR SAY JD NK GDL LAO. Contributed reagents/materials/analysis tools: MDG GWH GL SMS SAY KRM JD NK GDL LAO. Wrote the paper: NK GDL LAO. Enrolled patients: LAO.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Silicosis is a complex lung disease for which no successful treatment is available and therefore lung transplantation is a potential alternative. Tumor necrosis factor alpha (TNFalpha) plays a central role in the pathogenesis of silicosis. TNFalpha signaling is mediated by the transcription factor, Nuclear Factor (NF)-kappaB, which regulates genes controlling several physiological processes including the innate immune responses, cell death, and inflammation. Therefore, inhibition of NF-kappaB activation represents a potential therapeutic strategy for silicosis.
###end p 3
###begin title 4
Methods/Findings
###end title 4
###begin p 5
###xml 164 172 <span type="species:ncbi:9606">patients</span>
###xml 270 278 <span type="species:ncbi:9606">patients</span>
###xml 290 298 <span type="species:ncbi:9606">patients</span>
###xml 464 472 <span type="species:ncbi:9606">patients</span>
###xml 717 725 <span type="species:ncbi:9606">Patients</span>
###xml 840 848 <span type="species:ncbi:9606">patients</span>
###xml 1035 1040 <span type="species:ncbi:10090">mouse</span>
###xml 1163 1169 <span type="species:ncbi:9606">humans</span>
###xml 1381 1396 <span type="species:ncbi:10090">transgenic mice</span>
In the present work we evaluated the lung transplant database (May 1986-July 2007) at the University of Pittsburgh to study the efficacy of lung transplantation in patients with silicosis (n = 11). We contrasted the overall survival and rate of graft rejection in these patients to that of patients with idiopathic pulmonary fibrosis (IPF, n = 79) that was selected as a control group because survival benefit of lung transplantation has been identified for these patients. At the time of lung transplantation, we found the lungs of silica-exposed subjects to contain multiple foci of inflammatory cells and silicotic nodules with proximal TNFalpha expressing macrophage and NF-kappaB activation in epithelial cells. Patients with silicosis had poor survival (median survival 2.4 yr; confidence interval (CI): 0.16-7.88 yr) compared to IPF patients (5.3 yr; CI: 2.8-15 yr; p = 0.07), and experienced early rejection of their lung grafts (0.9 yr; CI: 0.22-0.9 yr) following lung transplantation (2.4 yr; CI:1.5-3.6 yr; p<0.05). Using a mouse experimental model in which the endotracheal instillation of silica reproduces the silica-induced lung injury observed in humans we found that systemic inhibition of NF-kappaB activation with a pharmacologic inhibitor (BAY 11-7085) of IkappaBalpha phosphorylation decreased silica-induced inflammation and collagen deposition. In contrast, transgenic mice expressing a dominant negative IkappaBalpha mutant protein under the control of epithelial cell specific promoters demonstrate enhanced apoptosis and collagen deposition in their lungs in response to silica.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Although limited by its size, our data support that patients with silicosis appear to have poor outcome following lung transplantation. Experimental data indicate that while the systemic inhibition of NF-kappaB protects from silica-induced lung injury, epithelial cell specific NF-kappaB inhibition appears to aggravate the outcome of experimental silicosis.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 188 191 188 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-American1">[1]</xref>
###xml 383 386 383 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-American1">[1]</xref>
###xml 551 554 551 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Mossman1">[2]</xref>
###xml 863 866 855 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Piguet1">[3]</xref>
###xml 694 698 <span type="species:ncbi:10090">Mice</span>
Chronic occupational or environmental exposure to silica is associated with the development of silicosis, a lung disease characterized by granulomatous inflammation and pulmonary fibrosis [1]. In spite of significant progress in its prevention, silicosis remains a major global health problem associated with a high morbidity and mortality for which no specific therapy is available [1]. Silica-induced inflammation is a complex process in which the interaction of silica particles with lung cells is followed by the release of inflammatory mediators [2]. Among these mediators, tumor necrosis factor alpha (TNFalpha) plays a fundamental role in the pathogenesis of silica-induced lung injury. Mice exposed to silica demonstrate enhanced TNFalpha production in their lungs in a manner that precedes the inflammatory response and the accumulation of lung collagen [3].
###end p 9
###begin p 10
###xml 82 85 78 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Baeuerle1">[4]</xref>
###xml 86 89 82 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Perkins1">[6]</xref>
###xml 305 308 297 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Baeuerle1">[4]</xref>
###xml 309 312 301 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Perkins1">[6]</xref>
###xml 641 644 592 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Perkins1">[6]</xref>
###xml 1294 1297 1206 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Baeuerle1">[4]</xref>
###xml 1298 1301 1210 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Perkins1">[6]</xref>
###xml 1604 1607 1508 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Baeuerle1">[4]</xref>
###xml 1608 1611 1512 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Perkins1">[6]</xref>
###xml 1720 1723 1620 1623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Perkins1">[6]</xref>
NF-kappaB is a transcription factor that plays a fundamental role in inflammation [4]-[6]. NF-kappaB is a protein complex formed from the homo or heterodimers of any of the five members of the rel transcription factor family [REL (c-Rel), RELA (p65), RELB (Rel B), NFKB1 (p50/p105), and NFKB2 (p52/p100)] [4]-[6]. Under basal conditions NF-kappaB is bound in the cell cytoplasm to IkappaB, a group [NFKBIA (IkappaBalpha), NFKBIB (IkappaBbeta), and NFKBIE (IkappaBepsilon) are the key members) of NF-kappaB sensitive proteins that limits NF-kappaB nuclear translocation and inhibits its ability to bind the promoter region of sensitive genes [6]. NF-kappaB activation can occur in several pathways: most commonly, it is triggered in a canonical manner in response to inflammatory cytokines (such as TNFalpha), engagement of T cell receptor, or lypopolysaccharide (LPS) that induces rapid phosphorylation, at Ser32 and Ser36 residues, of IkappaB by the IkappaB kinase complex [consisting of the catalytic subunits CHUK (IKKalpha) and IKBKB (IKKbeta)] and several copies of the regulatory subunit called NF-kappaB essential modifier. Phosphorylated IkappaBalpha undergoes ubiquitin-induced degradation by the 26S proteosome and allows the nuclear translocation of the NF-kappaB, NFKB1-RELA dimers [4]-[6]. A subset of NF-kappaB activating stimuli such as stimulation of CD40 activate the non-canonical, or alternative, pathway in which activation of catalytic subunits CHUK results in the formation of NFKB2 (p52) from p100 and the generation of NFKB2-RELB heterodimers that target distinct kappaB elements [4]-[6]. Activation of this alternative pathway of NF-kappaB is not associated with formation of NFKB1 (p50) dimers [6].
###end p 10
###begin p 11
###xml 148 151 144 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Chen1">[7]</xref>
###xml 152 155 148 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Kang1">[9]</xref>
###xml 324 328 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Hubbard1">[10]</xref>
###xml 329 333 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Ortiz1">[12]</xref>
###xml 535 539 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Hubbard1">[10]</xref>
###xml 541 545 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Porter1">[11]</xref>
###xml 547 551 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Sacks1">[13]</xref>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
Following inhalation into the lower respiratory tract silica particles interact with epithelial cells and macrophages inducing NF-kappaB activation [7]-[9]. Binding of NF-kappaB to DNA promotes the transcription of genes involved in mediating the inflammatory (TNFalpha) and fibrotic (collagens) responses to silica in mice [10]-[12]. Because of the potential importance of NF-kappaB in the pathogenesis of silicosis, this transcription factor has been considered a primary target to antagonize silica-induced inflammation in the lung [10], [11], [13]. However, the long-term biologic effects of inhibiting NF-kappaB in vivo in response to silica are unknown.
###end p 11
###begin p 12
###xml 404 408 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Pierce1">[14]</xref>
###xml 504 508 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Brockman1">[15]</xref>
###xml 510 514 494 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Skerrett1">[16]</xref>
###xml 167 175 <span type="species:ncbi:9606">patients</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
###xml 420 435 <span type="species:ncbi:10090">transgenic mice</span>
###xml 566 570 <span type="species:ncbi:10090">mice</span>
Due to the lack of treatment for silicosis, lung transplantation is considered the only a therapeutic alternative. In the present work we characterized the outcome of patients that received lung transplantation for the treatment of their silica-induced respiratory failure. We also treated silica exposed C57BL/6 mice with a pharmacologic inhibitor (BAY 11-7085) of NFKBIA (IkappaBalpha) phosphorylation [14] or exposed transgenic mice expressing a dominant negative NFKBIA (IkappaBalpha) mutant protein [15], [16] under the control of epithelial specific promoters mice to silica to determine whether the systemic or epithelial inhibition of NF-kappaB activation is a valid therapeutic approach in silicosis.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Study population
###end title 14
###begin p 15
###xml 762 766 762 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Thalbut1">[17]</xref>
###xml 992 996 992 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-1">[18]</xref>
###xml 998 1002 998 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-2">[19]</xref>
###xml 181 189 <span type="species:ncbi:9606">patients</span>
###xml 332 340 <span type="species:ncbi:9606">patients</span>
###xml 587 595 <span type="species:ncbi:9606">patients</span>
###xml 753 761 <span type="species:ncbi:9606">patients</span>
###xml 1161 1169 <span type="species:ncbi:9606">patients</span>
###xml 1489 1497 <span type="species:ncbi:9606">patients</span>
The University of Pittsburgh Institutional Review Board approved the procedures used in this study and information was minimized to comply with HIPPA regulations. We identified 990 patients that received lung transplantation at the University of Pittsburgh during the period of May 1986 to July 2007. From this database we selected patients that received lung transplantation for the diagnosis of silicosis (n = 13) and assessed the overall survival and rate of graft rejection, by measuring the development of bronchiolitis obliterans (BO). We compared the rate of rejection to that of patients with idiopathic pulmonary fibrosis (IPF) that was selected as a control group because survival benefit of lung transplantation has been identified for these patients [17]. Inclusion criteria for IPF included histological evidence of usual interstitial pneumonia (UIP) in the explanted lungs and fulfilled the criteria established by the American Thoracic Society and European Respiratory Society [18], [19]. Diagnosis of silicosis or UIP was unequivocally established by blind re-evaluation (S.Yousem). Upon further evaluation of explanted lungs, two of the twelve patients with diagnosis of silicosis demonstrated evidence of coexistent pneumoconiosis or Kaplan syndrome and were withdrawn for further analysis. Characterization of the TNFalpha expression and the NF-kappaB activation was conducted by immunohistochemistry in paraffin-embedded lung tissues (4 microm) isolated from silicosis patients at time of lung transplantation.
###end p 15
###begin title 16
Silica and BAY 11-7085 Treatment
###end title 16
###begin p 17
###xml 387 391 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Ortiz1">[12]</xref>
###xml 393 397 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Ortiz2">[20]</xref>
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Ortiz1">[12]</xref>
###xml 491 495 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Ortiz2">[20]</xref>
###xml 920 924 906 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Ortiz1">[12]</xref>
###xml 926 930 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Ortiz2">[20]</xref>
###xml 1604 1608 1580 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Ortiz1">[12]</xref>
###xml 1610 1614 1586 1590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Ortiz2">[20]</xref>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 942 946 <span type="species:ncbi:10090">mice</span>
###xml 1159 1163 <span type="species:ncbi:10090">Mice</span>
All procedures were approval by the Institutional Animal Care and Use Committee of the University of Pittsburgh. Specific pathogen-free female C57BL/6 (Charles River laboratories, Kingston, NY), and mice genetically deficient in both (p55p75-/-) TNF receptors (The Jackson Laboratory, Bar Harbor, ME) weighing 20 to 25 grams were housed in pathogen-free cabinets as previously described [12], [20]. Animals were exposed to silica (0.2 g/kg) or saline (control) as previously described [12], [20] and killed at selected times (3, 7, 14, and 28 d) after silica exposure. Prior to exposure, crystalline silica (alpha-quartz, average diameter: 1.7 microm, U.S. Silica Co., Berkeley Springs, WV) was sterilized (200degreesC, 16 h) to inactivate endotoxin contamination. Silica suspension in sterile 0.9% NaCl (Baxter Healthcare Corp., Deerfield, IL) was prepared by sonicating immediately prior to intratracheal instillation [12], [20]. Groups of mice received 10 mg of BAY 11-7085 (BIOMOL International L.P. Plymouth Meeting, PA)/Kg body weight/day/28 d by i.p. injection in 180 microl of vehicle (0.5% (w/v) methylcellulose in water) or vehicle alone (control). Mice were anesthetized with sodium pentobarbital (200 mg/kg i.p., Henry Schein, Indianapolis, IN) followed by exsanguination via severing of the posterior abdominal aorta. All the lung samples were harvested at a terminal anesthesia point, snap frozen in liquid nitrogen, and stored at -80degreesC for RNA or hydroxyproline content analysis. Lung hydroxyproline was determined according to the method of Kivirikko et al. as previously described [12], [20].
###end p 17
###begin title 18
###xml 42 57 <span type="species:ncbi:10090">transgenic mice</span>
Generation of CCSP and SPC-dnIkappaBalpha transgenic mice
###end title 18
###begin p 19
###xml 156 160 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Brockman1">[15]</xref>
###xml 234 238 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Hoyle1">[21]</xref>
###xml 344 353 316 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005689.s006">Method S1</xref>
###xml 588 592 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Skerrett1">[16]</xref>
###xml 185 188 <span type="species:ncbi:10116">rat</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 537 542 <span type="species:ncbi:9606">human</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 661 665 <span type="species:ncbi:10090">mice</span>
###xml 779 783 <span type="species:ncbi:10090">Mice</span>
To inhibit NFKBIA (IkappaBalpha) in the airway epithelium, a CCSP-dnIkappaBalpha construct was generated by cloning a dominant-negative (dn) IkappaB mutant [15] under the regulation of rat Clara cell secretory protein (CCSP) promoter [21]. Details of the generation of the CCSP-dnIkappaBalpha mice are included in the supplemental information (Method S1). In addition, transgenic SPC-dnIkappaBalpha mice (kind gift of Christopher Wilson) were generated at the University of Washington and have dnIkappaBalpha under the regulation of the human SPC (SFTPC) promoter as previously described [16]. CCSP- and SPC-dnIkappaBalpha mice were crossed with C57BL/6 strain mice for a minimum of 7 generations before used in experiments. Transgene negative littermates were used as controls. Mice were housed under specific-pathogen free conditions in filtered-air cages, and permitted unlimited access to sterile food and water.
###end p 19
###begin title 20
Morphology and Morphometry
###end title 20
###begin p 21
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Cavarra1">[22]</xref>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Gambelli1">[23]</xref>
Inflammatory cell infiltration was determined by morphometric assessment (conducted blindly by G. Lungarella) and expressed as percentage volume-densities of fibrosis [Vv(f)] was measured according to the stereological principle of Glagoleff and Weibel as previously described [22], [23]. Point counting was performed at a magnification of x100, by determining 20 random fields per slide and using a multipurpose grid to count 45 points/field to a total of 900 points/specimen. This method measures inflammatory cell infiltration within alveolar septae and alveolar spaces with deposition of extracellular matrix.
###end p 21
###begin title 22
Quantitative real-time polymerase chain reaction (qRT-PCR) assay
###end title 22
###begin p 23
###xml 578 598 570 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. TNF pathway group</italic>
###xml 764 785 756 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. NFKB pathway group</italic>
###xml 869 886 861 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. Cytokine group</italic>
###xml 1091 1099 1083 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005689.s005">Table S1</xref>
###xml 1396 1408 1370 1374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;C</sup>
###xml 1417 1421 1383 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-1">[18]</xref>
###xml 1455 1459 <span type="species:ncbi:10090">mice</span>
To adequately cover the TNFalpha and NF-kappaB pathway and targeted cytokines, 40 transcripts selected were analyzed by qRT-PCR. Total RNA was isolated with TRIzol reagent (Invitrogen, Carlsbad, CA) and quantity was assessed by absorbance (NanoDrop, Thermo Scientific, Pittsburgh, PA). RNA (100 ng) was reverse transcribed (High Capacity cDNA Archive Kit, Applied Biosystems Inc., Foster City, CA) and cDNA was PCR amplified with primers and TaqMan Universal PCR Master Mix (Applied Biosystems). Arranged into functional groups, primers (SABiosciences, Frederick, MD) included: A. TNF pathway group (19 transcripts): TNF, TNFSF10, TNFSF14, TNFRSF1A, TNFRSF1B, TNFRSF10B, CD27, CD40, LTBR, TNFAIP3, TRAF2, TRAF3, TRADD, TBK1, FADD, CFLAR, RIPK1, RIPK2, and MAP3K1, B. NFKB pathway group (9 transcripts): NFKB1, NFKB2. IKBKB, IKBKE, IKBKG, REL, RELA, RELB, and CHUK, and C. Cytokine group (12 transcripts mRNAs): CCL2, IL1B, IL6, CSF2, CSF3, IFNG, IRAK1, IRAK2, NLRP2, KAT2B, STAT1, and EGR1 (All abbreviations are current Entrez Gene official symbols and official full names are presented in Table S1). Analysis was performed with an Applied Biosystems 7900HT System (95degreesC 10 min; 40 cycles 95degreesC, 15 s; 60degreesC, 1 min). The expression of each transcript relative to Heat shock protein 90 kDa alpha (cytosolic), class B member 1 (HSP90AB1) transcript level was determined using the 2-DeltaDeltaCT method [18] and normalized to strain-matched mice exposed to saline.
###end p 23
###begin title 24
Northern Analysis and Ribonuclease Protected Assays
###end title 24
###begin p 25
###xml 139 143 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Ortiz1">[12]</xref>
###xml 145 149 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Ortiz2">[20]</xref>
###xml 151 155 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Gambelli1">[23]</xref>
Analysis of the expression of collagen, type I, alpha 1 (COL1alpha1), TNFalpha, and RPS18 (18S) mRNA was conducted as previously described [12], [20], [23]. Metalloproteinase 2 (MMP2), and tissue inhibitor of metalloproteinase 1 (TIMP1) transcript levels were determined by a ribonuclease protection assay (RiboQuanttrade mark, Becton, Dickinson and Company, Franklin Lakes, NJ).
###end p 25
###begin title 26
Isolation of Clara and Alveolar Epithelial type II (AEII) cells, and electrophoretic mobility Shift Assay (EMSA), and Western Blot assays
###end title 26
###begin p 27
###xml 106 110 106 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Corti1">[24]</xref>
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Warshamana1">[25]</xref>
###xml 199 209 199 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005689.s006">Methods S1</xref>
###xml 333 337 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Gambelli1">[23]</xref>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Gozal1">[26]</xref>
###xml 596 598 584 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
###xml 498 504 <span type="species:ncbi:9986">rabbit</span>
Clara and AEII cells were isolated from the lung of transgenic and wild-type mice as previously described [24], [25]. Complete description of the isolation protocol is included in supplemental data (Methods S1). Nuclear extracts from Clara cells, AEII cells, or the lungs of silica-treated mice were prepared as previously described [23], [26]. Complete description of the EMSA protocol is included in supplemental data. IkappaB expression was studied by proving proteins with an affinity purified rabbit polyclonal antibodies specific to total or phospho-IkappaB [PhosphoPlus IkappaB -alpha (Ser32) antibody kit, New England Biolabs, Ipswich, MA].
###end p 27
###begin title 28
Quantification of apoptosis in lung tissues by Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL)
###end title 28
###begin p 29
###xml 319 323 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Kuwano1">[27]</xref>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 265 270 <span type="species:ncbi:10090">mouse</span>
Apoptotic cells in lung tissues from mice treated with silica or silica plus Bay 11-7085 (n = 5 mice/group) was performed using a TUNEL assay (Travigen Laboratories, Gaithersburg, MD). The mean of the numbers of TUNEL-positive cells was determined using 3 sections/mouse (x400 light microscopy) as previously described [27].
###end p 29
###begin title 30
Statistics
###end title 30
###begin p 31
###xml 337 343 <span type="species:ncbi:10090">murine</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
We analyzed both overall survival and rejection-free survival, using the date of transplant as the start date of follow-up. Survival curves were computed using the Kaplan-Meier method. Differences in survival according to primary diagnosis were assessed using the logrank test and the Cox proportional hazards model. Differences between murine strains were analyzed using ANOVA with Fisher's PLSD test for pair-wise comparison (statview 4; Abacus Concept, INC., Berkeley, CA). The differences in transcript levels are expressed as fold change of silica-treated mice compared to saline exposed mice and significant differences were determined by One-way Analysis of Variance with Holm-Sidak all pairwise multiple comparison procedure. Values are expressed as mean+/-SEM, and p value<0.05 was considered significant.
###end p 31
###begin title 32
Results
###end title 32
###begin title 33
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients with silicosis have poor prognosis following lung transplantation
###end title 33
###begin p 34
###xml 72 79 72 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005689-t001">Table 1</xref>
###xml 782 791 778 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g001">Figure 1A</xref>
###xml 913 922 909 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g001">Figure 1A</xref>
###xml 23 31 <span type="species:ncbi:9606">patients</span>
###xml 137 145 <span type="species:ncbi:9606">patients</span>
###xml 236 244 <span type="species:ncbi:9606">patients</span>
###xml 388 396 <span type="species:ncbi:9606">patients</span>
###xml 438 446 <span type="species:ncbi:9606">patients</span>
###xml 466 474 <span type="species:ncbi:9606">patients</span>
###xml 764 772 <span type="species:ncbi:9606">patients</span>
###xml 828 836 <span type="species:ncbi:9606">patients</span>
###xml 990 998 <span type="species:ncbi:9606">patients</span>
###xml 1043 1051 <span type="species:ncbi:9606">patients</span>
###xml 1070 1078 <span type="species:ncbi:9606">patients</span>
###xml 1283 1291 <span type="species:ncbi:9606">patients</span>
###xml 1318 1326 <span type="species:ncbi:9606">patients</span>
###xml 1445 1453 <span type="species:ncbi:9606">patients</span>
Characteristics of the patients with silicosis and IPF are described in Table 1. We analyzed both overall and rejection-free survival of patients with silicosis or IPF, using the transplant date as the start of follow-up. Ten of the 11 patients with silicosis (average age 52.4+/-8.6 yr) received single lung transplantation (SLT) and 1 received a double lung transplant (DLT). Of the 79 patients with IPF (average age 54.0+/-9.9 yr), 71 patients received SLT and 8 patients received DLT. Survival at 30-, 60-, or 90-d did not differ between the two groups as assessed by the Kaplan-Meier method. Differences in survival according to primary diagnosis also were assessed using the log-rank test and the Cox proportional hazards model. Median survival of silicosis patients (2.4 yr, Figure 1A) was somewhat less than that of IPF patients (5.3 yr; lower confidence bounds 0.2: 2.8 yr; p = 0.07 by the logrank test; Figure 1A). This analysis is confounded by gender (i.e., no female silicosis patients) as survival differed between sexes for IPF patients. Thus, female IPF patients were transplanted at a significantly younger age (51.5+/-9 years) than their male counterpart (55.9+/-10.2 yr) and demonstrated a significant (p<0.005) survival difference (11.6 yr) when compared to male patients with IPF (3.5 yr). All 11 patients who received lung transplantation for silicosis died during the follow up, while only 37 deaths occurred among the 79 patients with IPF during follow-up. Transplantation type, SLT versus DLT, did not affect survival outcome.
###end p 34
###begin title 35
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients with silicosis have poor outcome following lung transplantation.
###end title 35
###begin p 36
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g001">Figure 1</xref>
###xml 82 90 <span type="species:ncbi:9606">patients</span>
Figure 1 illustrates the survival rates (1A) and the rejection free time (1B) for patients with idiopathic pulmonary fibrosis (IPF; n = 79) or silicosis (n = 11) following lung transplantation. Survival curves were computed using the Kaplan-Meier method. Differences in survival according to primary diagnosis were assessed using the logrank test and the Cox proportional hazards model as described in the text.
###end p 36
###begin title 37
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient Characteristics.
###end title 37
###begin p 38
###xml 51 59 <span type="species:ncbi:9606">Patients</span>
P-value denotes the statistical difference between Patients with IPF and those with silicosis.
###end p 38
###begin p 39
###xml 389 393 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Estenne1">[28]</xref>
###xml 456 465 454 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g001">Figure 1B</xref>
###xml 223 231 <span type="species:ncbi:9606">patients</span>
###xml 446 454 <span type="species:ncbi:9606">patients</span>
###xml 486 494 <span type="species:ncbi:9606">patients</span>
Rejection of the transplanted lung was defined as the development of bronchiolitis obliterans syndrome (BOS). BOS was defined by an irreversible (>/=20%) decrease in forced expiratory volume in one second (FEV1) using each patients' best post transplant FEV1 after lung transplant as baseline, and the development of obliterative bronchiolitis (OB) in lung biopsy of the transplanted lung [28]. The rate of graft rejection increased in silicosis patients (Figure 1B) as compared to IPF patients (p<0.05, by the logrank test). Median graft survival was 0.9 and 2.4 yr, respectively, for the silicosis and IPF groups. A lower confidence bound for the silicosis group was 0.22 yr; a 95% confidence interval for the IPF group was 1.5: 3.6 yr.
###end p 39
###begin title 40
Enhanced macrophage TNFalpha expression and epithelial NF-kappaB activation in silicosis
###end title 40
###begin p 41
###xml 350 359 342 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g002">Figure 2A</xref>
###xml 468 477 456 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g002">Figure 2A</xref>
###xml 656 665 640 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g002">Figure 2B</xref>
###xml 766 775 750 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005689.s001">Figure S1</xref>
###xml 928 937 904 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005689.s002">Figure S2</xref>
###xml 254 262 <span type="species:ncbi:9606">patients</span>
TNFalpha expression and NF-kappaB activation was determined by performing immune staining in paraffin embedded sections of lung tissues isolated from the lungs of subjects afflicted with silicosis at the time of lung transplantation. In all 11 silicosis patients, large areas of the lung parenchyma were replaced by coalescence of silicotic nodules (Figure 2A). These nodules contain fibrinous material, had few cells, and did not demonstrate TNFalpha immunostaining (Figure 2A). In contrast, TNFalpha immunostaining was evident in preserved regions of the lung parenchyma adjacent to the silicotic nodules, which was confined to primarily to macrophages (Figure 2B), and was particularly strong in macrophages that exhibit excessive silica particles in phagosomes (Figure S1). Immunostaining for NF-kappaB activation was predominantly detected in the nuclei of epithelial cells adjacent to TNFalpha immunostaining macrophages (Figure S2).
###end p 41
###begin title 42
TNFalpha expression in silicotic lung is predominantly identified in macrophages.
###end title 42
###begin p 43
Panel A show low photomicrograph (x200) of lung tissue isolated from a silica exposed subject at the time of lung transplantation. Lung parenchyma is replaced by silicotic nodule characterized by a dense palisade of fibroblast surrounding a central fibrinous core that is devoided of cells and abuts the distal airway. Alveolar macrophages accumulate in relatively normal alveolar areas adjacent to the silicotic nodule (circle). Panel B show high (x400) magnification of the area identified in panel A, illustrating immunochemistry signal with anti-TNFalpha antibody that is confined to cells with macrophage morphology.
###end p 43
###begin title 44
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Lung Transcripts for TNFalpha, NF-kappaB, and cytokines increased in silica-treated mice
###end title 44
###begin p 45
###xml 335 344 327 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g003">Figure 3A</xref>
###xml 349 358 341 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g003">Figure 3B</xref>
###xml 679 688 647 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g003">Figure 3C</xref>
###xml 751 760 719 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g003">Figure 3A</xref>
###xml 1055 1064 995 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g003">Figure 3C</xref>
###xml 1498 1507 1434 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g003">Figure 3C</xref>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 869 874 <span type="species:ncbi:10090">mouse</span>
To ascertain whether TNFalpha or NF-kappaB signaling pathways and targeted cytokines were altered in silica treated mice, 40 lung transcripts were assessed in the lung of C57BL/6 mice at 3, 7, 14 and 28 d after silica exposure. Overall, 26 transcripts increased (p<0.05) within 3 d and were slightly higher than the mean level at 7 d (Figure 3A and Figure 3B). At 28 d, 38 of the 40 transcripts were increased (only CHUK and EGR1 were not significantly increased). Of the 40 transcripts measured, TNFalpha increased the most (approximately90-fold). TNFalpha receptors, TNFRSF1B and TNFRSF1A, increased, as did transcripts that are rapidly induced by TNFalpha, TNFAIP3 and RIPK2 (Figure 3C). All 19 TNF signaling pathway transcripts increased by 28 d (Figure 3A). Albeit somewhat less the TNF signaling pathway, NF-kappaB signaling pathway transcripts also increased in mouse lung following silica exposure. At 28 d, NFKB1 (p50) increased approximately5-10 fold and Rel/NFKB family transcription factors (REL, RELA, RELB) increased approximately5-15 fold (Figure 3C). Only 1 (CHUK) of 9 transcripts in the NF-kappaB signaling pathway was not significantly different from control by 28 d. In addition, 11 of 12 cytokine transcripts increased significantly with the progression of treatment. Of these, cytokine controlling the production, differentiation, and function of monocytes/macrophages (CCL2 a.k.a. MCP1, and CSF2 a.k.a. GM-CSF), and of granulocytes (CSF2: a.k.a. G-CSF; CCL2) are noteworthy (Figure 3C). In addition, transcripts encoding interleukins (IL1B, IL6), IFNG, and the downstream transcription activator, STAT1, increased markedly (approximately8-20 fold at 28 d).
###end p 45
###begin title 46
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
Tumor necrosis factor alpha (TNFalpha), nuclear factor kappa B (NFKB) and associated cytokines increased in mouse lung following silica treatment.
###end title 46
###begin p 47
###xml 758 766 752 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005689.s005">Table S1</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
Mice (n = 5 C57BL/6J mice/group) were treated with silica, lung mRNA was obtained at 3, 7, 14, and 28 days, and 40 transcript levels were assessed by qRT-PCR. (A) Self-organizing map visualization of transcripts in Tree View. The order of the transcripts is greatest (top) to lowest (bottom) as measured on day 28. (B) Visualization of Mean Tendency of the 40 transcripts measured. Values are mean+/-standard error and *p<0.05 as determined by One way analysis of variance with all pairwise multiple comparison procedures (Holm-Sidak method). (C) Transcript levels of selected members of TNFalpha signaling, NFKB signaling, and downstream cytokine families. All abbreviations are current Entrez Gene official symbols and official full names are presented in Table S1.
###end p 47
###begin title 48
TNFalpha receptors mediate NF-kappaB activation in experimental silicosis
###end title 48
###begin p 49
###xml 187 191 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Ortiz1">[12]</xref>
###xml 193 197 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Ortiz2">[20]</xref>
###xml 199 203 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Hoyle1">[21]</xref>
###xml 430 438 410 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g004">Figure 4</xref>
###xml 906 914 862 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g004">Figure 4</xref>
###xml 1276 1284 1224 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g004">Figure 4</xref>
###xml 1524 1532 1472 1480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g004">Figure 4</xref>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 323 328 <span type="species:ncbi:10090">mouse</span>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
###xml 1156 1160 <span type="species:ncbi:10090">mice</span>
###xml 1219 1223 <span type="species:ncbi:10090">mice</span>
###xml 1647 1652 <span type="species:ncbi:10090">mouse</span>
We have previously reported that TNFalpha receptors play a fundamental role in experimental silicosis and TNFalpha receptor deficient mice are protected from silica-induced lung fibrosis [12], [20], [21]. Here we show that TNFalpha-receptor mediated signaling is an important determinant of the NF-kappaB activation in the mouse lung in response to silica. Instillation of silica particles increased phophorylated IkappaB moiety (Figure 4). This increase was followed by IkappaB rapid degradation and eventual disappearance of (total IkappaB) in the lungs of silica-sensitive C57BL/6 mice. In contrast to C57BL/6 mice, these changes in IkappaB did not take place in the lungs of double (p55p75) TNFalpha receptor deficient mice developed in the same silica-sensitive C57BL/6 genetic background. Silica-induced degradation of phospho IkappaB is associated with NF-kappaB activation in the lungs of C57BL/6 (Figure 4). Analysis of NF-kappaB gel shift in lung nuclear extracts show that silica induces two bands: a lower band representing the p50-p50 (NFKB1-NFKB1) homodimer, present in both the C57BL/6 and the double (p55p75-/-) TNFalpha receptor deficient mice, and an upper band, only observed in the lungs of C57BL/6 mice, representing the p50-p65 (NFKB1:RELA) heterodimer (Figure 4). Supershift assays confirmed that the lower band could be competed by excess cold, but not by mutant, probe while the upper band could be displaced by incubation of the nuclear extract with an antibody against the p50 or the p65 complex (Figure 4). These data indicate that silica induces a canonical, TNFalpha receptor-mediated, activation of NF-kappaB in the mouse lung.
###end p 49
###begin title 50
TNFalpha receptors mediate NF-kappaB activation in experimental silicosis.
###end title 50
###begin p 51
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 656 660 <span type="species:ncbi:10090">mice</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
###xml 849 854 <span type="species:ncbi:10090">mouse</span>
Western blot (upper panel) representing expression of total and phosphorylated IkappaB (phospho IkappaB) in the lungs of silica-sensitive C57BL/6, or double (p55/p75-/-) TNFalpha receptor deficient mice following the intratracheal instillation of silica particles as described in the text. Lower panel illustrates the DNA binding activity of NF-kappaB in crude nuclear extracts from whole lung isolated from C57BL/6, and double (p55/p75-/-) TNFalpha receptor deficient mice after silica exposure. Silica induces two bands: a lower band representing the p50-p50 homo-dimer, present in both the C57BL/6 and the double (p55p75-/-) TNFalpha receptor deficient mice, and an upper band, only observed in the lungs of C57BL/6 mice, representing the p50-p60 heterodimer. Excess probe represents NF-kappaB binding in lung nuclear extract of a silica-treated mouse, assayed in the presence of excess unlabelled oligonucleotide as a competitor. Competition assays were performed using 400 times excess of unlabeled probe or NF-kappaB mutant oligonucleotide (Santa Cruz). Supershifts were performed by adding to the binding mixture antibodies to p50 (sc1190X) or to p65 (sc372X) or against C-Jun/AP-1 (sc44X) (Santa Cruz) before adding the labeled probe to the mixture.
###end p 51
###begin p 52
###xml 158 166 146 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g004">Figure 4</xref>
###xml 370 378 354 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g005">Figure 5</xref>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
Following the early activation of NF-kappaB, lung IkappaB mRNA increased in silica-exposed C57BL/6 mice (not shown) and IkappaB protein returned to baseline (Figure 4). Enhanced NF-kappaB activation was appreciated in the lungs of silica-exposed C57BL/6 mice for the entire duration of the experiments, and it was readily demonstrated 14 and 28 d after silica exposure (Figure 5). Therefore, it is conceivable that inhibition of NF-kappaB activity could in turn modulate expression of NF-kappaB sensitive genes and alters the development of silica-induced lung injury in these mice.
###end p 52
###begin title 53
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Systemic inhibition of NF-kappaB activity ameliorates silica-induced lung injury in mice.
###end title 53
###begin p 54
###xml 442 449 434 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 686 693 670 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 949 956 933 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 1172 1179 1156 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 245 250 <span type="species:ncbi:10090">mouse</span>
###xml 420 425 <span type="species:ncbi:10090">mouse</span>
###xml 563 568 <span type="species:ncbi:10090">mouse</span>
###xml 770 775 <span type="species:ncbi:10090">mouse</span>
###xml 862 866 <span type="species:ncbi:10090">mice</span>
###xml 1083 1087 <span type="species:ncbi:10090">mice</span>
A) DNA binding activity of NF-kappaB in crude nuclear extracts from whole lung isolated from C57BL/6 mice 14 and 28 days after silica, or silica+BAY exposure. Excess probe represents NF-kappaB binding in lung nuclear extract of a silica-treated mouse, assayed in the presence of excess unlabelled oligonucleotide as a competitor. Antibody supershifts were performed using the nuclear extract of a C57BL/6 silica-treated mouse as described in Methods section. B) Northern blot analysis of TNFalpha, alpha1(I) collagen, and 18S (loading control) mRNA expression in mouse lung 14 days following the intratracheal injection of saline as control, silica alone, or silica+BAY as described in Methods section. C) The effect of BAY on metalloproteinase (MMPs) RNA expression in mouse lung following silica exposure. Total lung RNA was isolated from the lungs of C57BL/6 mice 14 days after control, silica, or silica+BAY and subjected to RPA as described in Methods section. D) The panels show low (x100) power magnification photomicrographs of the lung obtained from lung tissues of C57BL/6 mice exposed to saline as control (A), silica (B), or silica+BAY (C) as described in the Methods section. TB = terminal bronchiole. Bar = 20 microm. Gel illustrations are representative of 4 different experiments.
###end p 54
###begin title 55
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Systemic inhibition of NF-kappaB activity ameliorates silica-induced lung injury in mice
###end title 55
###begin p 56
###xml 462 466 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Pierce1">[14]</xref>
###xml 468 472 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Gambelli1">[23]</xref>
###xml 780 788 752 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g005">Figure 5</xref>
###xml 379 384 <span type="species:ncbi:9606">human</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
To investigate whether inhibiting systemic or lung epithelial cell-specific NF-kappaB activation is protective in the development of experimental silicosis we adopted two experimental approaches. Systemic inhibition of NF-kappaB activation was accomplished using a novel pharmacologic agent, BAY-117821, which irreversibly inhibits TNFalpha-induced phosphorylation of IkappaB in human endothelial cells, and NF-kappaB activation in silica stimulated macrophages [14], [23]. In preliminary studies, dose responses (2.5-50 mg/kg) were tested and 10 mg/kg bwt/d (180 microl 0.5% (w/v) methylcellulose i.p.) was capable of consistently inhibiting the silica-induced activation of NF-kappaB in multiple organs including the lungs of C57BL/6 mice without apparent toxicity to the mice (Figure 5).
###end p 56
###begin p 57
###xml 90 99 86 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g005">Figure 5A</xref>
###xml 287 294 275 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005689-t002">Table 2</xref>
###xml 296 305 284 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g003">Figure 3C</xref>
###xml 307 318 295 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g005">Figure 5B&amp;C</xref>
###xml 324 333 312 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005689.s003">Figure S3</xref>
###xml 465 472 453 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005689-t002">Table 2</xref>
###xml 474 483 462 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g005">Figure 5D</xref>
###xml 507 514 495 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005689-t002">Table 2</xref>
###xml 574 583 562 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005689.s004">Figure S4</xref>
###xml 589 596 577 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005689-t003">Table 3</xref>
###xml 707 716 691 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g005">Figure 5A</xref>
###xml 758 765 742 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005689-t002">Table 2</xref>
###xml 767 778 751 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g005">Figure 5B&amp;C</xref>
###xml 784 794 768 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005689.s003">Figures S3</xref>
###xml 870 879 854 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g005">Figure 5D</xref>
###xml 881 888 865 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005689-t002">Table 2</xref>
###xml 917 924 901 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005689-t003">Table 3</xref>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
Silica treatment induced NF-kappaB activation, 14 and 28 d, in the lungs of C57BL/6 mice (Figure 5A). Activation of NF-kappaB was associated with increased inflammatory (TNFalpha), fibrotic (COL1A1), and metalloproteinases (MMPs) transcripts in the lungs of silica-exposed C57BL/6 mice (Table 2, Figure 3C, Figure 5B&C, and Figure S3). Compared to control-treated mice, silica-exposed C57BL/6 mice developed fibrosis with increased percentage of fibrosis [(Vv(f)] (Table 2, Figure 5D), lung hydroxyproline (Table 2), and apoptotic cells, identified as TUNEL positive cells (Figure S4, and Table 3). Treatment of silica-exposed C57BL/6 mice with BAY 11-7085 compound inhibited the lung NF-kappaB activation (Figure 5A), inflammatory and fibrotic transcripts (Table 2, Figure 5B&C, and Figures S3), and histological evidence of inflammatory infiltrates, fibrotic lesions (Figure 5D, Table 2), and TUNEL positive cells (Table 3).
###end p 57
###begin title 58
The effect of BAY Treatment on Silica Induced Gene Expression.
###end title 58
###begin p 59
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Statistically significant different when compared to control-treated mice.
###end p 59
###begin p 60
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Statistically significant different when compared to silica exposed mice.
###end p 60
###begin title 61
The effect of BAY Treatment on Silica Induced Lung Injury.
###end title 61
###begin p 62
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Statistically significant different when compared to control-treated mice.
###end p 62
###begin p 63
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Statistically significant different when compared to silica exposed mice.
###end p 63
###begin p 64
###xml 169 173 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Brockman1">[15]</xref>
###xml 462 466 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Brockman1">[15]</xref>
###xml 468 472 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Skerrett1">[16]</xref>
###xml 558 566 526 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g006">Figure 6</xref>
###xml 888 896 848 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g006">Figure 6</xref>
###xml 1144 1152 1092 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g006">Figure 6</xref>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 231 234 <span type="species:ncbi:10116">rat</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
###xml 722 737 <span type="species:ncbi:10090">transgenic mice</span>
###xml 974 978 <span type="species:ncbi:10090">mice</span>
###xml 1138 1142 <span type="species:ncbi:10090">mice</span>
To achieve lung epithelial cell-specific inhibition of NF-kappaB activation, we used mice in which dominant-negative IkappaBalpha (dnIkappaBalpha:NFKBIA) mutant protein [15] is targeted to epithelial cells under the control of the rat Clara cell secretory protein (CCSP: Scgb1a1) or the human surfactant protein C (SPC:SFTPC) promoter respectively. These dnIkappaBalpha mutant mice, the mutant protein is resistant to phosphorylation and proteosomal degradation [15], [16] and inhibit NF-kappaB activation in those cells in which the transgene is expressed (Figure 6). To confirm that that NF-kappaB activation was impaired in the epithelium of these mice we isolated Clara or alveolar epithelial type II cells from these transgenic mice and non-transgenic littermate controls following exposure to silica. In vivo exposure (28 d) to silica readily induced NF-kappaB activation in Clara (Figure 6) or alveolar epithelial type II cells isolated from the littermate wild-type mice (not shown). In contrast, this NF-kappaB activation is greatly reduced in Clara or alveolar epithelial type II cells isolated from CCSP- or SPC-dnIkappaBalpha mice (Figure 6).
###end p 64
###begin title 65
Expression of a dominant-negative (dn) IkappaBalpha protein inhibits epithelial activation of NF-kappaB in response to silica.
###end title 65
###begin p 66
###xml 568 575 524 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 942 949 894 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 39 54 <span type="species:ncbi:10090">transgenic mice</span>
###xml 220 225 <span type="species:ncbi:10090">mouse</span>
###xml 302 307 <span type="species:ncbi:10090">mouse</span>
###xml 448 463 <span type="species:ncbi:10090">transgenic mice</span>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
###xml 920 925 <span type="species:ncbi:10090">mouse</span>
Lung sections from CCSP-dnIkappaBalpha transgenic mice were stained with antibodies against the modified (dnIkappaBalpha) IkappaBalpha peptide. Panel A shows strong staining in Clara cells of a dnIkappaBalpha transgenic mouse. Staining with the same antibody is absent in the non-transgenic littermate mouse in panel B. DNA binding activity of NF-kappaB in crude nuclear extracts from Clara (C) cells isolated from the lungs of CCSP-dnIkappaBalpha transgenic mice, or their littermate (wild-type) 28 days after exposure to silica or saline as controls as described in Methods section. Excess probe represents NF-kappaB binding in nuclear extract from Clara isolated from silica-exposed littermate wild type mice, assayed in the presence of excess unlabelled oligonucleotide as a competitor. Antibody supershifts were performed using the nuclear extract from Clara cells isolated form silica-exposed littermate wild type mouse as described in Methods section.
###end p 66
###begin p 67
###xml 121 128 113 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005689-t004">Table 4</xref>
###xml 290 297 278 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005689-t004">Table 4</xref>
###xml 444 451 424 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005689-t004">Table 4</xref>
###xml 700 708 664 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g007">Figure 7</xref>
###xml 1030 1037 974 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005689-t004">Table 4</xref>
###xml 1313 1320 1233 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005689-t005">Table 5</xref>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 666 670 <span type="species:ncbi:10090">mice</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
###xml 867 882 <span type="species:ncbi:10090">transgenic mice</span>
###xml 904 908 <span type="species:ncbi:10090">mice</span>
###xml 1059 1063 <span type="species:ncbi:10090">mice</span>
###xml 1130 1134 <span type="species:ncbi:10090">mice</span>
###xml 1155 1159 <span type="species:ncbi:10090">mice</span>
CCSP-dnIkappaBalpha mice reacted to silica exposure with decreased lung inflammation as compared to littermate controls (Table 4). This attenuated inflammatory response was associated decreased TNFalpha transcripts and inflammatory cell infiltration [(Vv(f)] at 28 d after silica exposure (Table 4). In contrast to these effects on inflammation, lung hydroxyproline deposition increased in CCSP-dnIkappaBalpha mice than in littermate controls (Table 4). Similarly, CCSP-dnIkappaBalpha mice and wild-type littermate mice had nearly equivalent increases in collagen and TIMP1 transcripts. However, silica-induced lung MMP2 transcripts were less in CCSP-dnIkappaBalpha mice as compared to C57BL/6 mice (Figure 7). Because NF-kappaB can function as an anti-apoptotic factor, we evaluated the effect of expressing the dnIkappaBalpha mutant in the lung epithelium of these transgenic mice. CCSP-dnIkappaBalpha mice had increased apoptosis (TUNEL positive cells) in their lungs when compared to their non-transgenic littermate controls (Table 4). SPC-dnIkappaBalpha mice reacted to silica exposure similar to that of CCSP-dnIkappaBalpha mice. SPC-dnIkappaBalpha mice had decreased infiltrating cells, but accumulated increased hydroxyproline and TUNEL positive cells in their lungs when compared to littermate controls (Table 5).
###end p 67
###begin title 68
Clara cell expression of a dominant-negative (dn) IkappaBalpha protein alters TNFalpha, and MMP2, but not alpha1(I) collagen and TIMP-1, mRNA expression in response to silica.
###end title 68
###begin p 69
###xml 251 258 243 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 142 147 <span type="species:ncbi:10090">mouse</span>
###xml 320 335 <span type="species:ncbi:10090">transgenic mice</span>
###xml 444 449 <span type="species:ncbi:10090">mouse</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 715 730 <span type="species:ncbi:10090">transgenic mice</span>
Densitometry analysis of Northern blots of TNF, alpha1(I) collagen, MMP2, TIMP-1, and 18S (loading control) mRNA expression in CCSP-dnIkappaB mouse lung 28 days following the intratracheal injection of saline as control, or silica as described in the Methods section. Compared to their wild type littermates, CCSP-dnIkB transgenic mice significantly inhibited (P<0.05) the enhanced expression of TNFalpha and MMP2 mRNA induced by silica in the mouse lung. Figure illustrate results obtained from five set of mice exposed to silica or saline as control. * Indicates statistically significant difference compared to saline treated mice. dagger Indicates statistically significant difference compared to wild-type non-transgenic mice.
###end p 69
###begin title 70
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Silica Induced Lung Injury in CCSP-dnIKBalpha mice.
###end title 70
###begin p 71
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Statistically significant different when compared to control-treated mice.
###end p 71
###begin p 72
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Statistically significant different when compared to silica exposed NT littermate mice.
###end p 72
###begin title 73
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Silica Induced Lung Injury in SPC-dnIkappaBalpha mice.
###end title 73
###begin p 74
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Statistically significant different when compared to control-treated mice.
###end p 74
###begin p 75
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Statistically significant different when compared to silica exposed NT littermate mice.
###end p 75
###begin title 76
Discussion
###end title 76
###begin p 77
###xml 301 309 <span type="species:ncbi:9606">patients</span>
###xml 436 441 <span type="species:ncbi:10090">mouse</span>
###xml 578 584 <span type="species:ncbi:9606">humans</span>
###xml 855 870 <span type="species:ncbi:10090">transgenic mice</span>
Silicosis remains a severe lung disease for which no successful treatment is available. Here, we report that silica exposure leads to large portion of the lung replaced by coalescing nodules with proximal TNFalpha expressing macrophage and NF-kappaB activation in epithelial cells. We also found that patients with silicosis had poor survival and experienced early rejection of their lung grafts following lung transplantation. Using a mouse experimental model of silicosis in which the endotracheal instillation of silica reproduces the silica-induced inflammation observed in humans we show that systemic inhibition of NF-kappaB activation with a pharmacologic inhibitor (BAY 11-7085) of IkappaBalpha (NFKBIA) phosphorylation significantly decreases silica induced inflammation and fibrosis, with reduced collagen deposition and apoptosis. In contrast, transgenic mice expressing a dominant negative IkappaBalpha mutant protein under the control of epithelial specific promoters demonstrate enhanced collagen deposition and apoptosis in their lungs in response to silica.
###end p 77
###begin p 78
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-WHO1">[29]</xref>
###xml 258 262 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Goodwin1">[30]</xref>
###xml 344 348 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-OSHA1">[31]</xref>
###xml 349 353 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Morbidity1">[34]</xref>
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-OSHA1">[31]</xref>
###xml 419 423 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Morbidity1">[34]</xref>
###xml 620 624 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-OSHA1">[31]</xref>
###xml 626 630 626 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Yassin1">[33]</xref>
###xml 632 636 632 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Morbidity1">[34]</xref>
###xml 844 848 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Morbidity1">[34]</xref>
###xml 1132 1136 1132 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Morbidity1">[34]</xref>
###xml 1387 1391 1363 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-WHO1">[29]</xref>
###xml 290 296 <span type="species:ncbi:9606">people</span>
###xml 791 799 <span type="species:ncbi:9606">patients</span>
###xml 978 984 <span type="species:ncbi:9606">people</span>
The worldwide incidence and prevalence of silicosis is uncertain, but is increasing in developing countries [29]. In the United States the incidence and prevalence of silicosis is under-estimated as silicosis is not a reportable disease and under recognized [30]. Approximately 1.7 million people in the US are occupationally exposed to silica [31]-[34] and as many as 119,000 are exposed above permissible levels [31]-[34] with the majority of these individuals employed in mining, construction or maritime activities. Consequently, an estimated 3,600-7,300 newly recognized silicosis cases in the US from 1987 to 1996 [31], [33], [34]. Although preventive measures have significantly decreased the mortality attributable to silica the reality is that that a large number of silica-exposed patients are still dying as a result of this disease [34]. While mortality is widely spread across the country, nine states reported high rates of mortality, more than 2-3 deaths/million people/year, with clusters of counties where mining is an important activity contributing disproportionably (>14.8 deaths/million/year) to this mortality [34]. A global health issue, silicosis levels are rising in developing countries. For example, the silicosis burden in China is growing (with approximately7-10,000 new cases/yr) and is extensive (>500,000 cases resulting in approximately24,000 deaths/yr) [29].
###end p 78
###begin p 79
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Porter2">[35]</xref>
###xml 392 395 392 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-American1">[1]</xref>
###xml 553 557 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Vermeire1">[36]</xref>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Burton1">[37]</xref>
###xml 525 532 <span type="species:ncbi:9606">patient</span>
Once established, silica-induced inflammation progresses even after occupational exposure has ended, a phenomenon clearly reproduced in experimental animals [35]. Using conventional anti-inflammatory agents does not control silica-induced inflammation and therefore, because of this lack of successful treatment, lung transplantation has been proposed as an effective therapeutic alternative [1]. However, very little published data is available to support this postulate. A SLT was reported in a 23-yr male in 1972 with the patient surviving 10 months [36]. More recently, the Copenhagen National Lung Transplant Group reported 4 translation cases, but no discussion of their outcome was available [37].
###end p 79
###begin p 80
###xml 481 485 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Thalbut1">[17]</xref>
###xml 186 194 <span type="species:ncbi:9606">patients</span>
###xml 284 292 <span type="species:ncbi:9606">patients</span>
###xml 335 343 <span type="species:ncbi:9606">patients</span>
###xml 510 518 <span type="species:ncbi:9606">patients</span>
###xml 655 663 <span type="species:ncbi:9606">patients</span>
###xml 824 832 <span type="species:ncbi:9606">patients</span>
###xml 854 862 <span type="species:ncbi:9606">patients</span>
In this report, we describe our experience at the University of Pittsburgh (a post industrial city located in the heart of the mining industry in Western Pennsylvania) with 11 silicosis patients that received lung transplantation for this disease from 1986-2007. The outcome of these patients was contrasted with that of a group of 79 patients that received lung transplantation for IPF, a diffuse parenchymal lung disease for which lung transplantation confers a survival benefit [17]. Our data indicate that patients with silicosis appear to have poor survival and greater rate of graft rejection, despite identical protocols for immunosupression, than patients with IPF following lung transplantation. Our analysis is limited by the small size and more importantly by gender differences in lung transplant survival among patients with IPF. Female IPF patients were transplanted at a younger age and had better survival outcome and lower rejection rates when compared to their male counterparts. The reasons for the gender difference in survival following lung transplantation are unknown and are worthy of additional study.
###end p 80
###begin p 81
###xml 682 685 666 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Piguet1">[3]</xref>
###xml 763 767 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Porter1">[11]</xref>
###xml 769 773 753 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Ortiz1">[12]</xref>
###xml 990 993 962 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Piguet1">[3]</xref>
###xml 995 999 967 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Piguet2">[38]</xref>
###xml 1145 1149 1113 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Ortiz1">[12]</xref>
###xml 1151 1155 1119 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Ortiz2">[20]</xref>
###xml 1392 1396 1356 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Corbett1">[39]</xref>
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
###xml 209 215 <span type="species:ncbi:9606">humans</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
###xml 1160 1166 <span type="species:ncbi:9606">humans</span>
To further our understanding of the pathogenesis of silicosis we used well-characterized mouse model in which silica exposure produces lung inflammation and parenchymal nodules comparable to those observed in humans exposed to silica. Using this experimental model, silica induced rapid (with in minutes) and persistent (identified 14 and 28 d after a single intratracheal instillation) activation of NF-kappaB in the lung and that TNFalpha receptors greatly contribute to this activation. Previously, TNFalpha has been implicated as a central mediator in the pathogenesis of silicosis. Piguet et al. reported that the exposure of mice to silica increased lung TNFalpha mRNA levels [3], which preceded the development of lung inflammation and collagen deposition [11], [12]. Furthermore, these investigators were able to abrogate silica-induced inflammation and lung fibrosis with the administration of anti TNFalpha antibodies or TNFalpha receptors that antagonized the bioactive TNFalpha [3], [38]. Similarly, we have previously reported that animals deficient in TNFalpha receptors are protected from silica-induced inflammation and fibrosis [12], [20]. In humans, compelling evidence indicates that polymorphism of the TNFalpha gene promoter (TNF-308: denominated TNF-A allele 2) is associated with silicosis disease severity, although not with disease frequency, in South African miners [39].
###end p 81
###begin p 82
###xml 162 166 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Beutler1">[40]</xref>
###xml 168 172 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Bazzoni1">[41]</xref>
###xml 447 451 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Ortiz1">[12]</xref>
###xml 659 662 627 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Chen1">[7]</xref>
###xml 663 667 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Sacks1">[13]</xref>
###xml 278 283 <span type="species:ncbi:10090">mouse</span>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
TNFalpha mediates its biologic action by binding to two receptors of tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A: p55) and 1B (TNFRSF1B: p75) [40], [41]. In this work we find that TNFalpha receptors contribute to the canonical activation of NF-kappaB in the mouse lung in response to silica. Previously, we reported that double TNFalpha receptor deficient mice failed to activate NF-kappaB in their lungs in response to silica [12]. Centrally located in the TNFalpha signal pathway, NF-kappaB activation mediates the inflammatory and cell survival effects of TNFalpha and therefore constitutes a logical target for antagonism in silicosis [7]-[13]. The long-term effects of such inhibition are not well understood.
###end p 82
###begin p 83
###xml 358 362 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Pierce1">[14]</xref>
###xml 334 339 <span type="species:ncbi:9606">human</span>
The present work underscores the importance of the specificity of the NF-kappaB antagonism during lung inflammation. Thus, both the inflammatory and fibrotic responses to silica was ameliorated by systemic inhibition of NF-kappaB activation with BAY-117821, an irreversibly inhibitor of TNFalpha-induced phosphorylation of IkappaB in human endothelial cells [14]. In contrast, although the lung epithelial cell specific inhibition of NF-kappaB also reduced TNFalpha expression and the infiltration of inflammatory cells in the lung, it accentuated the apoptotic process and enhanced the fibrosis response by promoting the deposition of collagen and decreasing the matrix remodeling in the lung in response to silica.
###end p 83
###begin p 84
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Rich1">[42]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Borges1">[45]</xref>
###xml 448 452 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Rich1">[42]</xref>
###xml 453 457 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Borges1">[45]</xref>
###xml 512 516 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Hashimoto1">[46]</xref>
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Phillips1">[47]</xref>
###xml 701 705 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Phillips1">[47]</xref>
###xml 1052 1056 1048 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Cherla1">[48]</xref>
These data stress two aspects of the pathophysiology of silicosis. The first aspect is that although silica enters the body via the respiratory system it triggers a systemic response characterized by stimulation of bone marrow and the migration of bone marrow-derived cells into the lung [42]-[45]. Published data in experimental models of lung fibrosis indicate that although this response is dominated by migration of neutrophils and lymphocytes [42]-[45] it also includes the homing of profibrotic fibrocytes [46], [47]. Characterized by their expression of hematopoietic markers (such as CD45) fibrocytes also express collagen and contribute actively to the deposition of this protein in the lung [47]. Mobilization and homing of fibrocytes into the lung is facilitated by their expression of chemokine receptors, such as CXCR4, and the enhanced expression in the injured lung of the cognate ligands for these receptors (i.e., stromal cell derived factor1 alpha and CXCL12). Because expression of these ligands is sensitive to NF-kappaB regulation [48], early inhibition of the NF-kappaB activation could reduce the migration of these cells and protect the lung from further injury.
###end p 84
###begin p 85
###xml 571 575 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Yatera1">[49]</xref>
###xml 1184 1188 1160 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005689-Giangreco1">[50]</xref>
###xml 166 181 <span type="species:ncbi:10090">transgenic mice</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
###xml 673 677 <span type="species:ncbi:10090">mice</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
The second aspect is that epithelial cells responses contribute to inflammation in silicosis. Consistent with this statement, CCSP-dnIkappaB as well as SPC-dnIkappaB transgenic mice exhibit reduced TNFalpha mRNA expression and are less inflamed than their wild-type littermates. However, these mice exhibit more robust accumulation of collagen in response to silica. These data underscore the importance of the epithelial specific inhibition of NF-kappaB, which has previously been reported to increase MMPs in the lungs of silica-exposed animals depleted of Clara cells [49]. In contrast, we find that silica induced expression of the MMP inhibitor, TIMP1, in the lung of mice, and this enhanced expression was not altered in the lungs of the CCSP-dnIkappaB mice. Therefore, these data suggest that the decrease MMPs expression originated by the Clara cell specific inhibition of NF-kappaB would create an imbalance of the ability of lung to remodel in favor of matrix deposition. Our data are also consistent with the hypothesis that lung epithelium harbors a small number of stem cells that are resistant to toxins and are fundamental to the maintenance of homeostasis of the lung [50]. Therefore, it is plausible that expression of the IkappaB repressor under specific epithelial promoters, such as CCSP or SPC, results in reduced activation of NF-kappaB on these cells rendering them more sensitive to apoptosis thus compromising their ability to repair the injured epithelium.
###end p 85
###begin p 86
###xml 187 195 <span type="species:ncbi:9606">patients</span>
###xml 596 602 <span type="species:ncbi:9606">humans</span>
In summary, the present work re-emphasizes that silicosis remains a serous lung disease for which no specific treatment is successful. Although limited by its size, our data support that patients with silicosis appear to have poor outcome following lung transplantation. Experimental data indicate that TNFalpha receptors contribute to the silica-induced activation of NF-kappaB in the lung and our data suggest that early and systemic antagonism of this signal transduction ameliorates lung inflammation and benefits outcome in experimental silicosis. Because systemic antagonism of TNFalpha in humans is currently possible with a variety of strategies such as use of antibodies or recombinant receptors that bind and antagonize TNFalpha it would be appropriate to prospectively study the potential therapeutic role of such antagonism in modulating silica-induced lung injury and improving the outcome of lung transplantation for silicosis.
###end p 86
###begin title 87
Supporting Information
###end title 87
###begin p 88
###xml 142 151 138 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005689-g003">Figure 3B</xref>
Silica exposed Macrophages express TNFalpha. High (x400) magnification photomicrograph, using polarized light of the same area illustrated in Figure 3B, to illustrate that TNFalpha expression is predominantly located in macrophages laden with bi-refringent silica particles.
###end p 88
###begin p 89
(7.06 MB TIF)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin p 91
TNFalpha and NF-kappaB expression in silicosis. Panel A show photomicrograph (x100) illustrating hematoxyllin and eosin staining of silicotic nodule involving a terminal airway in lung tissue isolated from a silica exposed subject at the time of lung transplantation. Insert (circle) represents an area adjacent to the silicotic nodule to illustrate sequential HE (D x200), and immunohistochemistry staining against TNFalpha in interstitial macrophages (arrows) loaded with dust (E x200), or nuclear localization on NF-kappaB in adjacent epithelial cells (E x200).
###end p 91
###begin p 92
(5.84 MB TIF)
###end p 92
###begin p 93
Click here for additional data file.
###end p 93
###begin p 94
###xml 308 315 304 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
###xml 185 190 <span type="species:ncbi:10090">mouse</span>
The Effect of BAY treatment on silica-induced gene expression in the mouse lung. Northern blot analysis of TNF, alpha1(I) collagen, TIMP-1, and 18S (loading control) mRNA expression in mouse lung 28 days following the intratracheal injection of saline as control, silica alone, or silica+BAY as described in Methods section. Gel is representative of result obtained with three different sets of animal exposures.
###end p 94
###begin p 95
(0.34 MB TIF)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin p 97
###xml 270 277 266 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 544 550 536 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Method</xref>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 496 501 <span type="species:ncbi:10090">mouse</span>
The effect of systemic or lung epithelial specific NF-kappaB inhibition on the induction of apoptosis (TUNEL staining) in the lung of silica exposed mice. Apoptosis was characterized by terminal deoxynucleotidyltransferase dUTP nick end-labeling (TUNEL) as described in Methods section. The panels show low (x100) power magnification photomicrographs of the lung obtained from lung tissues of C57BL/6 mice exposed to saline as control (A), silica (B), silica+BAY (D), or SPC-dnIkappaB transgenic mouse (E) exposed to silica as described in the Method section. Panel C show high (x400) magnification of TUNEL positive cells identified in B. Panel F illustrates negative staining (by omission of treatment with deoxynucleotidyltransferase enzyme) of a silica-exposed tissue used as control to demonstrate stain specificity.
###end p 97
###begin p 98
(10.28 MB TIF)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
(0.07 MB DOC)
###end p 100
###begin p 101
Click here for additional data file.
###end p 101
###begin p 102
File containing description of supplemental methods
###end p 102
###begin p 103
(0.05 MB DOC)
###end p 103
###begin p 104
Click here for additional data file.
###end p 104
###begin p 105
###xml 230 234 <span type="species:ncbi:10090">mice</span>
The authors have no conflicting financial interest. The authors would like to acknowledge Dr. Christopher Wilson, at the Department of Immunology at the University of Washington in Seattle, for his kind gift of SPC-dnIkappaBalpha mice.
###end p 105
###begin title 106
References
###end title 106
###begin article-title 107
Adverse effects of crystalline silica exposure.
###end article-title 107
###begin article-title 108
Mechanisms in the pathogenesis of asbestosis and silicosis.
###end article-title 108
###begin article-title 109
Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis.
###end article-title 109
###begin article-title 110
NF-kappaB: ten years after.
###end article-title 110
###begin article-title 111
The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation.
###end article-title 111
###begin article-title 112
Integrating cell-signalling pathways with NF-kappaB and IKK function.
###end article-title 112
###begin article-title 113
NF-kappaB, a pivotal transcription factor in silica-induced diseases.
###end article-title 113
###begin article-title 114
###xml 72 77 <span type="species:ncbi:9606">human</span>
Persistent depletion of I kappa B alpha and interleukin-8-expression in human pulmonary epithelial cells exposed to quartz particles.
###end article-title 114
###begin article-title 115
Silica induces Nucler factor-kappaB activation trough tyrosine phosphorylation of IkappaBalpha in RAW264.7 macrophages.
###end article-title 115
###begin article-title 116
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Activation of NF-kappaB dependent gene expression by silica in lungs of luciferase reporter mice.
###end article-title 116
###begin article-title 117
###xml 37 41 <span type="species:ncbi:10116">rats</span>
Time course of pulmonary response of rats to inhalation of crystalline silica: NF-kappaB activation, inflammation, cytokine production, and damage.
###end article-title 117
###begin article-title 118
###xml 124 130 <span type="species:ncbi:10090">murine</span>
Tumor necrosis factor receptor deficiency alters metalloproteinase 13/tissue inhibitor of metalloproteinase 1 expression in murine silicosis.
###end article-title 118
###begin article-title 119
###xml 41 45 <span type="species:ncbi:10116">rats</span>
Silica-induced pulmonary inflammation in rats: activation of NF-kappaB and suppression by dexamethasone.
###end article-title 119
###begin article-title 120
Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo.
###end article-title 120
###begin article-title 121
Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation.
###end article-title 121
###begin article-title 122
Respiratory epithelial cells regulate lung inflammation in response to endotoxin.
###end article-title 122
###begin article-title 123
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Survival benefit of lung transplantation for patients with Idiopathic pulmonary fibrosis.
###end article-title 123
###begin article-title 124
Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). American Thoracic Society (2000)
###end article-title 124
###begin article-title 125
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. (2002). This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by ERS Executive Committee, June 2001.
###end article-title 125
###begin article-title 126
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Upregulation of the p75 but not the p55 mRNA during silica and bleomycin-induced lung injury in mice.
###end article-title 126
###begin article-title 127
###xml 46 50 <span type="species:ncbi:10090">Mice</span>
Hyperinnervation of the Airways in Transgenic Mice Overexpressing Nerve Growth Factor.
###end article-title 127
###begin article-title 128
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Genetic deficiency of alpha1-PI in mice influences lung responses to bleomcyin.
###end article-title 128
###begin article-title 129
Phosphorylation of Tumor Necrosis Factor Receptor 1 (p55) protects macrophages from silica-induced apoptosis.
###end article-title 129
###begin article-title 130
###xml 33 39 <span type="species:ncbi:10090">murine</span>
Isolation and primary culture of murine alveolar type II cells.
###end article-title 130
###begin article-title 131
###xml 29 30 22 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 140 141 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 53 58 <span type="species:ncbi:10090">Mouse</span>
TNF-alpha, PDGF, and TGF-beta1 Expression by Primary Mouse Bronchiolar-Alveolar Epithelial and Mesenchymal Cells: TNF-alpha Induces TGF-beta1.
###end article-title 131
###begin article-title 132
###xml 28 34 <span type="species:ncbi:10090">murine</span>
Silica-induced apoptosis in murine macrophage: involvement of TNF-alpha and NF-kappaB activation.
###end article-title 132
###begin article-title 133
Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis.
###end article-title 133
###begin article-title 134
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.
###end article-title 134
###begin article-title 135
Previously undetected silicosis in New Jersey decedents.
###end article-title 135
###begin article-title 136
Occupational exposure to crystalline silica. Semiannual regulatory agenda.
###end article-title 136
###begin article-title 137
Estimating the total number of newly recognized silicosis cases in the United States.
###end article-title 137
###begin article-title 138
Occupational exposure to crystalline silica dust in the United States, 1988-2003.
###end article-title 138
###begin article-title 139
Silicosis Mortality, Prevention, and Control-United States 1968-2002.
###end article-title 139
###begin article-title 140
###xml 47 51 <span type="species:ncbi:10116">rats</span>
Progression of lung inflammation and damage in rats after cessation of silica inhalation.
###end article-title 140
###begin article-title 141
###xml 82 85 <span type="species:ncbi:9606">man</span>
Respiratory function after lung homotransplantations with a ten-month survival in man.
###end article-title 141
###begin article-title 142
The Copenhagen National Lung Transplant Group: Survival after Single Lung, Double Lung, and Hearth-Lung Transplantation.
###end article-title 142
###begin article-title 143
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice.
###end article-title 143
###begin article-title 144
Polymorphisms in the tumor necrosis factor-alpha gene promoter may predispose to severe silicosis in black South African miners.
###end article-title 144
###begin article-title 145
Unraveling function in the TNF ligand and receptor families.
###end article-title 145
###begin article-title 146
The tumor necrosis factor ligand and receptor families.
###end article-title 146
###begin article-title 147
An erytropietic stimulating factor similar to erythropoietin released by macrophages after treatment with silica.
###end article-title 147
###begin article-title 148
###xml 120 125 <span type="species:ncbi:9940">sheep</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
Regulation of bone marrow lymphocyte production. IV. Cells mediating the stimulation of marrow lymphocyte production by sheep red blood cells: studies in anti-IgM-suppressed mice, athymic mice, and silica-treated mice.
###end article-title 148
###begin article-title 149
###xml 107 111 <span type="species:ncbi:10116">rats</span>
A biphasic Response to Silica. I. Immunostimulation is restricted to the early stage of silicosis in Lewis rats.
###end article-title 149
###begin article-title 150
Fas ligand triggers pulmonary silicosis.
###end article-title 150
###begin article-title 151
Bone marrow-derived progenitor cells in pulmonary fibrosis.
###end article-title 151
###begin article-title 152
Circulating fibrocytes traffic to the lung in response to CXCL12 and mediate fibrosis.
###end article-title 152
###begin article-title 153
Stromal cell-derived factor 1 alpha-induced chemotaxis in T cells is mediated by nitric oxide signalling pathways.
###end article-title 153
###begin article-title 154
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Increased expression of matrix metalloproteinase in Clara cell-ablated mice inhaling crystalline silica.
###end article-title 154
###begin article-title 155
Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction.
###end article-title 155
###begin p 156
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 156
###begin p 157
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: United States Public Health Service Grants ES10859, HL071953 (to L.A. Ortiz) and HL073745 (to NK) and by a generous donation of the Simmons family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 157

